A new study reveals that weight lost with GLP-1 drugs, such as semaglutide, is regained within a year after stopping ...

Eli Lilly’s Zepbound transformed weight loss drug market since debut 18 months ago 4.5 million people reportedly taking Lilly ...

The drug coverage provision does not mention any specific drug by name, but it could include the GLP-1 agonists, such as ...

Hims & Hers is pitching consumers on a GLP-1 weight loss injection that will cost 85% less than brand-name drugs like Wegovy.

Pharmacy benefit manager CVS Caremark drops Zepbound coverage, estimating 10-15% savings while Eli Lilly offers self-pay ...

A large network meta-analysis ranked eight GLP-1 receptor agonists for glycemic, weight, and safety outcomes in adults with ...

Do those on Zepbound have to switch to Wegovy after Caremark drops Zepbound from preferred coverage? What options are there?

As weight-loss drugs like semaglutide and tirzepatide dominate global headlines, a new nationwide survey shows that 87 per ...

Business Insider spoke to Eli Lilly's new president of cardiometabolic health, who shared the company's aggressive incretin ...

Clinic Secret is a telehealth provider specializing in prescription therapies for weight loss. It connects patients with U.S.-licensed doctors who review medical information and prescribe medications, ...

Weight loss jabs will be given to 3,000 people in a trial to explore whether they can get people back into work, The i Paper ...

Rosie O'Donnell, who's been opening up about her weight-loss journey online, celebrated her progress in a new post.